Amid an intensifying debate over how Washington should counter China’s rapid ascent in the biotech sector, a growing chorus of policymakers and biotech insiders is urging the Treasury Department to expand the newly codified COINS Act to include biotechnology—a move
read moreThe potential $7 billion buyout deal in the radiopharmaceutical space could be weeks away, Bloomberg reported, citing people familiar with the matter. More: Radiopharmaceutical outfit Lantheus mulls potential B takeover by Curium: Bloomberg Source: fierce
read more
Data shows survival benefit in BRAFV600E‑mutant metastatic colorectal cancer More: Pierre Fabre Laboratories secures CHMP backing for first‑line BRAFTOVI regimen Source: News
read more
Findings strengthen rationale for EMERALD trial of engineered macrophage therapy RTX001 More: Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis Source: News
read moreKorea’s SK bioscience has signed a technology transfer and manufacturing deal with the Colombian government which will allow the South American nation to produce the company’s chickenpox vaccine SKYVaricella. More: SK bioscience links up with Colombia to enable local production
read moreMore than three years after Gilead Sciences’ hepatitis D drug bulevirtide was rebuffed by the FDA on manufacturing and delivery concerns, the treatment has redeemed itself by scoring a green light in the U.S. More: After prior FDA manufacturing snub,
read more© 1994 - 2026 B.M. Pharmaceuticals